Bacteria, food, and cancer

F1000 Biology Reports

Volumn 3, Issue 1, 2011, Pages

  Rooks, Michelle G ^a   Garrett, Wendy S ^a,b,c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FATTY ACID;

CANCER GROWTH; CANCER PREVENTION; CANCER RISK; DIABETES MELLITUS; DIET; DIETARY INTAKE; ENERGY METABOLISM; ENTERITIS; ESCHERICHIA COLI; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; NEOPLASM; NONHUMAN; OBESITY; REVIEW; SYMBIOSIS;

EID: 79960107709     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B3-12     Document Type: Review

References (32)

1. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009, 15:1016-22. F1000 Factor 6 Evaluated by Jean Pieters 18 Nov 2009
2. Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell 2010, 140:883-99. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
3. Yu H, Pardoll D, Jove R: STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009, 9:798-809. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
4. Rakoff-Nahoum S, Medzhitov R: Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007, 317:124-7. F1000 Factor 12 Evaluated by Patrick S Moore 10 Jul 2007, Maria Rescigno 25 Jul 2007, Lora Hooper 26 Jul 2007, Wendy Garrett 19 May 2011
5. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper HS, Itzkowitz SH, Abreu MT: Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133:1869-81. F1000 Factor 8 Evaluated by Kim Barrett 09 Jan 2008
6. Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, España C, Ungaro R, Harpaz N, Cooper HS, Elson G, Kosco-Vilbois M, Zaias J, Perez MT, Mayer L, Vamadevan AS, Lira SA, Abreu MT: Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis 2010, [Epub ahead of print]. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
7. Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, Herdman S, Varki N, Corr M, Lee J, Raz E: ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 2010, 16:665-70. F1000 Factor 6 Evaluated by Charles Brenner 21 Jul 2010
8. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI: Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102:11070-5. F1000 Factor 6 Evaluated by Eric Stabb 08 Feb 2006
9. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-31. F1000 Factor 25 Evaluated by David Robertson 02 Jan 2007, Joel Elmquist 08 Jan 2007, Matthias Maiwald 08 Jan 2007, Liang Tong 09 Jan 2007, Joanna Goldberg 11 Jan 2007, Marc Lecuit 11 Jan 2007, Stefan Kaufmann 17 Jan 2007, Joe Heitman 01 Feb 2007, David Bilder 21 Feb 2007
10. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI: The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1:6ra14. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
11. Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI: Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 2008, 6:776-88. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
12. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-6. F1000 Factor 11 Evaluated by Andrew S Neish 06 Nov 2009, Silvana Curci 10 Nov 2009, Erez Raz 07 Jun 2010
13. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H: Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-7. F1000 Factor 12 Evaluated by David Cook 18 Feb 2011, David Alpers 25 Feb 2011, Lora Hooper 28 Feb 2011, Matthew Parsek 09 Mar 2011
14. Hu S, Dong TS, Dalal SR, Wu F, Bissonnette M, Kwon JH, Chang EB: The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS One 2011, 6:e16221. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
15. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Doré J, Westerhuis JA, Van de Wiele T: Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4531-8.
16. Gross G, Jacobs DM, Peters S, Possemiers S, van Duynhoven J, Vaughan EE, van de Wiele T: In vitro bioconversion of polyphenols from black tea and red wine/grape juice by human intestinal microbiota displays strong interindividual variability. J Agric Food Chem 2010, 58:10236-46. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
17. Kemperman RA, Bolca S, Roger LC, Vaughan EE: Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 2010, 156:3224-31. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
18. Larrosa M, González-Sarrías A, Yáñez- Gascón MJ, Selma MV, Azorín-Ortuño M, Toti S, Tomás-Barberán F, Dolara P, Espín JC: Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 2010, 21:717-25. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
19. González-Sarrías A, Larrosa M, Tomás-Barberán FA, Dolara P, Espín JC: NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br J Nutr 2010, 104:503-12. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
20. Friedman M: Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 2007, 51:116-34. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
21. Vastag B: Soy and prostate cancer study results mixed. J Natl Cancer Inst 2007, 99:1364-5. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
22. Lampe JW: Emerging research on equol and cancer. J Nutr 2010, 140:1369S-72S. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
23. Huycke MM, Gaskins HR: Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004, 229:586-97. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
24. Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR: DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 2010, 51:304-14. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
25. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ: Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010, 44:354-60. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
26. Human Microbiome Project home page. [http://hmpdacc.org/]
27. NIH HMPWorking Group, Peterson J, Garges S, GiovanniM, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, et al.: The NIH Human Microbiome Project. Genome Res 2009, 19:2317-23. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
28. MetaHIT - Metagenomics of the Human Intestinal Tract. [http://www.metahit.eu/]
29. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, FernandesGR, Tap J, Bruls T, Batto JM, Bertalan M, BorruelN,Casellas F, Fernandez L,Gautier L,Hansen T, HattoriM,Hayashi T, KleerebezemM, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB,Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, et al.: Enterotypes of the human gut microbiome. Nature 2011, 473:174-80. F1000 Factor 9 Evaluated by Ann Stock 28 Apr 2011, Wendy Garrett 19 May 2011
30. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, et al.: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65. F1000 Factor 10 Evaluated by Scott Lesley 22 Mar 2010, Paul Cotter 04 May 2010, Wendy Garrett 19 May 2011
31. Nicholson JK, Lindon JC: Systems biology: Metabonomics. Nature 2008, 455:1054-6. F1000 Factor 6 Evaluated by Wendy Garrett 19 May 2011
32. Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, Redinbo MR: Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010, 330:831-5. F1000 Factor 8 Evaluated by Nikolay Dokholyan 15 Nov 2010, Nicholas Meanwell 23 Nov 2010, Wendy Garrett 19 May 2011